@article{JTD12546,
author = {Hui Ning and Ming Liu and Lina Wang and Yang Yang and Nan Song and Xiaoxiong Xu and Jin Ju and Gening Jiang},
title = {Clinicopathological features of Chinese lung cancer patients with epidermal growth factor receptor mutation},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {3},
year = {2017},
keywords = {},
abstract = {Background: Epidermal growth factor receptor (EGFR) gene was the major causative gene of lung cancer and also the specific treatment target. It is necessary to analyze the genotype and phenotype characters of patients.
Methods: We investigated 1,034 lung cancer patients in this study. The collected clinicopathological parameters included gender, age at diagnosis, smoking status, pathological TNM stage, tumor morphology and location, visceral pleural invasion as well as histological type.
Results: Almost 50% participants had EGFR mutations. L858R in exon 21 was the most common type. Concomitant mutation, 19 del and L858R, were detected in 20 patients. Compared to patients with exon 19 del or L858R mutations solely, they were inclined to have small size adenocarcinomas which occurred in bilateral and invaded the visceral pleura. The tyrosine kinases inhibitors (TKIs)-resistant mutation, insertions in exon 20, was detected in 11 patients.
Conclusions: The summarized clinicopathological features will help clinicians to implement the feasible treatment plan.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/12546}
}